Health Condition 1: O- Medical and Surgical
Conditions
Interventions
Intervention1: Inj. Ondanstetron: Inj. Ondanstetron 0.1 mg/kg diluted to 5 ml with 0.9% normal saline in a 5 ml syringe, administered 30 min prior to subarachnoid block
Control Intervention1: Inj. Gra
Sponsors
Dr Shwetha Odeyar S
Eligibility
Inclusion criteria
Inclusion criteria: 1.ASA Physical status II parturients 2.Parturients undergoing elective lower segment caesarean section under subarachnoid blockade
Exclusion criteria
Exclusion criteria: 1.Patient refusal or unable to give written informed consent. E.g.: psychiatric patients 2.Patients with known allergy to study drugs 3.Pre-operative use of study drugs 4.Administration of opioids / vasodilator drugs 5.Intraoperative blood transfusion 6.Preoperative shivering / temperature >=37.2°C or 7.Parkinsonâ??s disease or any other extrapyramidal disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 5-point shivering scoreTimepoint: Baseline, Before study drug, After study drug, After Subarachnoid block (5 min), 10 min, 15 min, 20 min, 25 min, 30 min, 1 hour, 1.5 hours, 2 hours, 2.5 hours, 3 hours, At modified Bromage 6 | — |
Secondary
| Measure | Time frame |
|---|---|
| SafetyTimepoint: Baseline, Before study drug, After study drug, After Subarachnoid block (5 min), 10 min, 15 min, 20 min, 25 min, 30 min, 1 hour, 1.5 hours, 2 hours, 2.5 hours, 3 hours, At modified Bromage 6 | — |
Countries
India
Contacts
Public ContactDr Shriker Sangviker
BGS Global Institute of Medical Sciences
Outcome results
None listed